BackEvaxion Biotech A/S Overview

Evaxion Biotech A/S Other Liabilities

Latest other liabilities for EVAX: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Evaxion Biotech A/S Other Liabilities History

Loading

Evaxion Biotech A/S vs. peers: Other Liabilities Comparison

Loading

Evaxion Biotech A/S Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Evaxion Biotech A/S (EVAX) FAQ

The latest other liabilities for EVAX is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Evaxion Biotech A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, EVAX's other liabilities moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Evaxion Biotech A/S's operating scale or balance-sheet position.

A other liabilities figure of $0 for EVAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EVAX's other liabilities ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Evaxion Biotech A/S's other liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.